Panalgo and HealthEconomics.Com Host Webinar on Successful ICER Strategies
Panalgo and HealthEconomics.Com hosted a webinar detailing strategies that lead to successful evaluation by the Institute for Clinical and Economic [...]
Preparing a Successful ICER Strategy: Lessons from the Frontlines
Consequential prescription drug pricing decisions in the United States increasingly involve high-stakes interactions between the manufacturer and the Institute for Clinical and Economic Review (ICER).
MMIT and Evaluate Acquire Panalgo to Streamline RWE and Ultimately Improve Patient Outcomes
Managed Markets Insight & Technology (MMIT) and Evaluate announced their acquisition of healthcare analytics company Panalgo. This acquisition will streamline [...]
Whitepaper on Tailoring Your Novel Therapeutic to ICER Standards
ICER (the Institute for Clinical and Economic Review) is an independent nonprofit organization dedicated to the fair evaluation of prescription [...]
Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics
Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to [...]
